Table 1

The clinical and pathological characteristics of 42 cases of prostate cancer and prostate hyperplasia

group

clinical and pathological characteristics


Mean age (range)

Prostate cancer

68.40 ± 9.55 (57–85)

prostate hyperplasia

64.18 ± 11.74 (45–81)

Histologic examination

Prostate cancer

adenocarcinoma

prostate hyperplasia

Fibromuscuadenomaoid node, adenomaoid node, leiomyomaoid node and fibrohemangioid

Pathological evaluation

Prostate cancer

Gleason grade IV 10(45.5%) and Gleason grade V 12(54.5%)

prostate hyperplasia

Moderate hyperplasia 12(60%) and severe hyperplasia 8(40%)

Volume(cm3)

Prostate cancer

78.53 ± 29.75

prostate hyperplasia

45.25 ± 18.97

Local invasion and metastasis

Prostate cancer

Local invasion 14(63.4) and metastasis 2(9%)

prostate hyperplasia

no

Level of prostate specific antigen in blood(ng/ml)

Prostate cancer

68.57 ± 50.43

prostate hyperplasia

20.21 ± 3.27


Zhang et al. Journal of Experimental & Clinical Cancer Research 2008 27:62   doi:10.1186/1756-9966-27-62

Open Data